首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.
【24h】

Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.

机译:对世卫组织III级星形细胞肿瘤患者进行的替莫唑胺放疗与单纯护理标准术后放疗的比较评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Outcome after radiochemotherapy (RCHT) with temozolomide (TMZ) versus radiotherapy (RT) for WHO grade III astrocytic tumors was evaluated. No significant difference in overall survival or progression-free survival between both groups was calculated. RCHT seems not to result in an improved outcome. Further randomized studies are needed to support these results.
机译:评价了替莫唑胺(TMZ)放疗(RTHT)与放疗(RT)对WHO III级星形细胞肿瘤的结果。两组之间的总生存期或无进展生存期无显着差异。 RCHT似乎并不能改善病情。需要进一步的随机研究以支持这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号